Kolexia
Allez Matthieu Gastro-entérologie
Allez Matthieu
Gastro-entérologie
Hôpital Saint-Louis
Paris, France
315 Activités
2.3 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Crohn Maladies inflammatoires intestinales Rectocolite hémorragique Colite Nécrose Inflammation Maladies auto-immunes Ulcère COVID-19

Collaborateurs

Voir plus
Bouhnik Yoram
Bouhnik Yoram
Cmc Ambroise Pare Hartmann Site 25, Neuilly-sur-Seine, France
Laharie David
Laharie David
Hôpital Haut-lévêque, Pessac, France
Peyrin-Biroulet Laurent
Peyrin-Biroulet Laurent
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Nancey Stephane
Nancey Stephane
Hôpital Lyon Sud, Pierre-Bénite, France

Industries

Voir plus
Janssen
65 collaboration(s)
Dernière en 2023
IQVIA
17 collaboration(s)
Dernière en 2023
Galapagos SASU
16 collaboration(s)
Dernière en 2023
Amgen
13 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Interobserver agreement of current and new proposed endoscopic scores for postoperative recurrence in Crohn’s disease
Gastrointestinal endoscopy   08 mars 2024
Infliximab desensitization in patients with inflammatory bowel diseases: a safe therapeutic alternative.
Scandinavian journal of gastroenterology   14 février 2024
USTAP: USTekinumab in Fistulising Perianal Crohn's Disease (CD): The USTAP CD Study
Essai Clinique (Janssen)   18 janvier 2024
National diagnostic and care protocols (NDCP) for hematopoietic stem cell transplantation in autoimmune diseases.
La Revue de medecine interne   13 janvier 2024
Outcomes and endpoints of postoperative recurrence in Crohn's Disease: systematic review and consensus conference.
Journal of Crohn's & colitis   19 décembre 2023
ABTECT - Maintenance: A Randomized, Double-blind, Multicenter Phase III Study to Evaluate the Long-term Efficacy and Safety of ABX464 25 mg or 50 mg Once Daily as a Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Essai Clinique (Abivax S.A.)   15 décembre 2023
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Active Ulcerative Colitis
Essai Clinique (Abivax S.A.)   15 décembre 2023
EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis : A Double Blinded Randomized Clinical Trial
Essai Clinique (CHU Rennes)   20 novembre 2023
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAID.
Journal of Crohn's & colitis   20 octobre 2023
Serious immune-related upper gastrointestinal toxicity of immune checkpoint inhibitors: a multicenter case series.
Journal of gastroenterology and hepatology   14 septembre 2023